For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260216:nRSP1807Ta&default-theme=true
RNS Number : 1807T MyCelx Technologies Corporation 16 February 2026
16 February 2026
MYCELX Technologies Corporation
("MYCELX" or the "Company" (AIM: MYX)
Director Dealing
The Company announces that it was notified on 13 February 2026 by Gareth
Kaminski-Cook, Non-executive Chairman of the Board of Directors of the
Company, that:
- on 11 February 2026, he purchased 2,350 common shares in the Company
of US$0.025 each ("Common Shares"), at a price of £0.47 per Common Share; and
- on 12 February 2026, he purchased 2,100 common shares in the Company
of US$0.025 each ("Common Shares"), at a price of £0.46 per Common Share.
Following these transactions, Mr. Kaminski-Cook holds 4,450 Common Shares
representing 0.02 per cent of the total issued capital of the Company.
For further information please contact:
MYCELX Technologies Corporation
Connie Mixon, CEO Tel: +1 888 306 6843
Kim Slayton, CFO
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)
Giles Balleny /Callum Davidson/Elysia Bough (Corporate Finance)
Harriet Ward (Corporate Broking) Tel: +44 20 7220 0500
Jasper Berry / Michael Johnson (Sales)
Notification of transactions of persons discharging managerial responsibility
or connected persons
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Gareth Kaminski-Cook
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name MYCELX Technologies Corporation
b) LEI 213800UJZINIK2VD1G48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Common shares of US$0.025
ISIN: US62847T2024
b) Nature of the transaction Purchase of Common Shares in GBP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.47 2,350
d) Aggregated information
- Aggregated volume n/a
- Price n/a
e) Date of the transaction 11/02/2026
f) Place of the transaction London Stock Exchange (AIM)
d)
Aggregated information
- Aggregated volume
- Price
n/a
n/a
e)
Date of the transaction
11/02/2026
f)
Place of the transaction
London Stock Exchange (AIM)
Notification of transactions of persons discharging managerial responsibility
or connected persons
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Gareth Kaminski-Cook
2 Reason for the notification
a) Position/status Non-Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name MYCELX Technologies Corporation
b) LEI 213800UJZINIK2VD1G48
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Common shares of US$0.025
ISIN: US62847T2024
b) Nature of the transaction Purchase of Common Shares in GBP
c) Price(s) and volume(s)
Price(s) Volume(s)
£0.46 2,100
d) Aggregated information
- Aggregated volume n/a
- Price n/a
e) Date of the transaction 12/02/2026
f) Place of the transaction London Stock Exchange (AIM)
d)
Aggregated information
- Aggregated volume
- Price
n/a
n/a
e)
Date of the transaction
12/02/2026
f)
Place of the transaction
London Stock Exchange (AIM)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFVIFEIRLIR
Copyright 2019 Regulatory News Service, all rights reserved